The whistleblowing drama behind Astellas’s suspension from the ABPI
(2019) In BMJ: British Medical Journal 366.- Abstract
- The Japanese drug company Astellas has had its knuckles rapped for wrongdoing four times in less than three years. Now Deborah Cohen, Shai Mulinari, and Piotr Ozieranski reveal fresh claims about the treatment of an employee who offered to help it clean up its act
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/72e40f79-030c-426c-94ee-d690ef123645
- author
- Cohen, Deborah ; Mulinari, Shai LU and Ozieranski, Piotr
- organization
- publishing date
- 2019-07-02
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMJ: British Medical Journal
- volume
- 366
- article number
- 1453
- publisher
- BMJ Publishing Group
- external identifiers
-
- scopus:85068472995
- pmid:31266743
- ISSN
- 1756-1833
- DOI
- 10.1136/bmj.l4353
- project
- What can be learnt from the new pharmaceutical industry payment disclosures? A network and policy analysis of ties between companies and health professionals and organisations
- language
- English
- LU publication?
- yes
- id
- 72e40f79-030c-426c-94ee-d690ef123645
- date added to LUP
- 2019-07-03 14:37:52
- date last changed
- 2023-04-09 20:44:28
@article{72e40f79-030c-426c-94ee-d690ef123645,
abstract = {{The Japanese drug company Astellas has had its knuckles rapped for wrongdoing four times in less than three years. Now Deborah Cohen, Shai Mulinari, and Piotr Ozieranski reveal fresh claims about the treatment of an employee who offered to help it clean up its act}},
author = {{Cohen, Deborah and Mulinari, Shai and Ozieranski, Piotr}},
issn = {{1756-1833}},
language = {{eng}},
month = {{07}},
publisher = {{BMJ Publishing Group}},
series = {{BMJ: British Medical Journal}},
title = {{The whistleblowing drama behind Astellas’s suspension from the ABPI}},
url = {{http://dx.doi.org/10.1136/bmj.l4353}},
doi = {{10.1136/bmj.l4353}},
volume = {{366}},
year = {{2019}},
}